These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1134 related articles for article (PubMed ID: 17560054)
21. The bactericidal/permeability-increasing protein (BPI), a potent element in host-defense against gram-negative bacteria and lipopolysaccharide. Elsbach P; Weiss J Immunobiology; 1993 Apr; 187(3-5):417-29. PubMed ID: 8330906 [TBL] [Abstract][Full Text] [Related]
22. The role of bactericidal/permeability-increasing protein as a natural inhibitor of bacterial endotoxin. Marra MN; Wilde CG; Collins MS; Snable JL; Thornton MB; Scott RW J Immunol; 1992 Jan; 148(2):532-7. PubMed ID: 1729370 [TBL] [Abstract][Full Text] [Related]
23. Characterization and expression analysis of bactericidal permeability-increasing protein (BPI) antimicrobial peptide gene from channel catfish Ictalurus punctatus. Xu P; Bao B; He Q; Peatman E; He C; Liu Z Dev Comp Immunol; 2005; 29(10):865-78. PubMed ID: 15896843 [TBL] [Abstract][Full Text] [Related]
24. Acylation of SC4 dodecapeptide increases bactericidal potency against Gram-positive bacteria, including drug-resistant strains. Lockwood NA; Haseman JR; Tirrell MV; Mayo KH Biochem J; 2004 Feb; 378(Pt 1):93-103. PubMed ID: 14609430 [TBL] [Abstract][Full Text] [Related]
25. Antimicrobial activity of Bac7 fragments against drug-resistant clinical isolates. Benincasa M; Scocchi M; Podda E; Skerlavaj B; Dolzani L; Gennaro R Peptides; 2004 Dec; 25(12):2055-61. PubMed ID: 15572192 [TBL] [Abstract][Full Text] [Related]
26. Presence of bactericidal/permeability-increasing protein in human and rat skin. Takahashi M; Horiuchi Y; Tezuka T Exp Dermatol; 2004 Jan; 13(1):55-60. PubMed ID: 15009116 [TBL] [Abstract][Full Text] [Related]
27. [Resistance of mastitis pathogens in northern Germany]. Schröder A; Hoedemaker M; Klein G Berl Munch Tierarztl Wochenschr; 2005; 118(9-10):393-8. PubMed ID: 16206927 [TBL] [Abstract][Full Text] [Related]
28. Enhancement of neonatal innate defense: effects of adding an N-terminal recombinant fragment of bactericidal/permeability-increasing protein on growth and tumor necrosis factor-inducing activity of gram-negative bacteria tested in neonatal cord blood ex vivo. Levy O; Sisson RB; Kenyon J; Eichenwald E; Macone AB; Goldmann D Infect Immun; 2000 Sep; 68(9):5120-5. PubMed ID: 10948134 [TBL] [Abstract][Full Text] [Related]
29. Differential effects of bactericidal/permeability-increasing protein (BPI) analogues on retinal neovascularization and retinal pericyte growth. Rauniyar RK; Suzuma K; King AL; Aiello LP; King GL Invest Ophthalmol Vis Sci; 2002 Feb; 43(2):503-9. PubMed ID: 11818397 [TBL] [Abstract][Full Text] [Related]
30. From infection to autoimmunity: a new model for induction of ANCA against the bactericidal/permeability increasing protein (BPI). Schultz H Autoimmun Rev; 2007 Mar; 6(4):223-7. PubMed ID: 17317612 [TBL] [Abstract][Full Text] [Related]
31. In vitro evaluation of the antimicrobial effect of commercially available mastitis medications combined with EDTA-Tris on bacteria that cause mastitis in cattle. Wooley RE; Ritchie BW; Kemp DT; Burnley CA Vet Ther; 2002; 3(2):150-6. PubMed ID: 19750746 [TBL] [Abstract][Full Text] [Related]
32. [Antimicrobial peptides/proteins--application to the therapy of sepsis]. Sawa T; Kurahashi K Masui; 1999 Nov; 48(11):1186-93. PubMed ID: 10586550 [TBL] [Abstract][Full Text] [Related]
33. Mechanisms of action of bactericidal/permeability-increasing protein BPI on reconstituted outer membranes of gram-negative bacteria. Wiese A; Brandenburg K; Carroll SF; Rietschel ET; Seydel U Biochemistry; 1997 Aug; 36(33):10311-9. PubMed ID: 9254630 [TBL] [Abstract][Full Text] [Related]
34. In vitro activity of novel in silico-developed antimicrobial peptides against a panel of bacterial pathogens. Romani AA; Baroni MC; Taddei S; Ghidini F; Sansoni P; Cavirani S; Cabassi CS J Pept Sci; 2013 Sep; 19(9):554-65. PubMed ID: 23893489 [TBL] [Abstract][Full Text] [Related]
35. In vitro activity of MSI-78 alone and in combination with antibiotics against bacteria responsible for bloodstream infections in neutropenic patients. Giacometti A; Cirioni O; Kamysz W; D'Amato G; Silvestri C; Licci A; Nadolski P; Riva A; Lukasiak J; Scalise G Int J Antimicrob Agents; 2005 Sep; 26(3):235-40. PubMed ID: 16122911 [TBL] [Abstract][Full Text] [Related]
36. Preferential binding of the neutrophil cytoplasmic granule-derived bactericidal/permeability increasing protein to target bacteria. Implications and use as a means of purification. Mannion BA; Kalatzis ES; Weiss J; Elsbach P J Immunol; 1989 Apr; 142(8):2807-12. PubMed ID: 2539411 [TBL] [Abstract][Full Text] [Related]
37. Tigecycline in vitro activity against gram-negative and gram-positive pathogens collected in Italy. Roveta S; Marchese A; Debbia EA Chemotherapy; 2008; 54(1):43-9. PubMed ID: 18073470 [TBL] [Abstract][Full Text] [Related]
38. Increasing extended-spectrum beta-lactamase production and quinolone resistance among Gram-negative bacilli causing intra-abdominal infections in the Asia/Pacific region: data from the Smart Study 2002-2006. Ko WC; Hsueh PR J Infect; 2009 Aug; 59(2):95-103. PubMed ID: 19564044 [TBL] [Abstract][Full Text] [Related]
39. The bovine salivary proteins BSP30a and BSP30b are independently expressed BPI-like proteins with anti-Pseudomonas activity. Haigh B; Hood K; Broadhurst M; Medele S; Callaghan M; Smolenski G; Dines M; Wheeler T Mol Immunol; 2008 Apr; 45(7):1944-51. PubMed ID: 18055015 [TBL] [Abstract][Full Text] [Related]
40. In vitro efficacy of the novel peptide CECT7121 against bacteria isolated from mastitic dairy cattle. Sparo MD; Jones DG; Sánchez Bruni SF Lett Appl Microbiol; 2009 Feb; 48(2):187-92. PubMed ID: 19141040 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]